Northern Trust’s Firefly Neuroscience AIFF Stock Holding History

Northern Trust’s Portfolio AIFF Stock Details AIFF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.4K	Hold	15,764	–	–	﹤0.01%	4291
2025 Q4	$13.8K	Buy	15,764 +396	+3%	+$738	﹤0.01%	4417
2025 Q3	$44.7K	Hold	15,368	–	–	﹤0.01%	4294
2025 Q2	$43.5K	Hold	15,368	–	–	﹤0.01%	4252
2025 Q1	$60.4K	Buy	+15,368	New	+$70.7K	﹤0.01%	4203
2023 Q4	–	Sell	-614	Closed	-$4.76K	–	4558
2023 Q3	$4.76K	Hold	614	–	–	﹤0.01%	4437
2023 Q2	$5.62K	Hold	614	–	–	﹤0.01%	4510
2023 Q1	$5.33K	Hold	614	–	–	﹤0.01%	4563
2022 Q4	$8.84K	Hold	614	–	–	﹤0.01%	4585
2022 Q3	$18K	Hold	614	–	–	﹤0.01%	4565
2022 Q2	$25K	Hold	614	–	–	﹤0.01%	4589
2022 Q1	$97K	Buy	+614	New	+$83K	﹤0.01%	4349

Other funds holding AIFF

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Northern Trust's AIFF Position: Q1 2026 in Review

Northern Trust held its Firefly Neuroscience (AIFF) position steady in Q1 2026 at 15,764 shares worth $34.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4291.

Northern Trust first reported a position in AIFF in Q1 2022 and has held it in 12 quarters since. The position peaked at $97K in Q1 2022. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

Northern Trust held 15,764 shares of Firefly Neuroscience worth $34.4K as of Q1 2026.
Northern Trust left its Firefly Neuroscience share count unchanged in Q1 2026.
Firefly Neuroscience made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4291 holding.
Northern Trust first reported a position in Firefly Neuroscience in Q1 2022 and has held it in 12 quarters since.
Northern Trust's Firefly Neuroscience position peaked at $97K in Q1 2022.
23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.